Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02468986 · ClinicalTrials.gov registry record
Study of Venous Endothelial Cells in Rheumatoid Arthritis
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 56
- Enrollment target
NCT02468986 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 56 participants.
The verdict
NCT02468986 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
Heart disease is the major contributor of early death in rheumatoid arthritis (RA) and is not influenced by traditional risk factors. Blood vessel dysfunction has been associated with heart disease and complications such as heart attack. The vessel dysfunction is thought to be mediated in part to inflammation. RA patients have evidence of vessel dysfunction seen on ultrasound that improves after medications are given. The purpose of this study is to evaluate patients with controlled or uncontrolled rheumatoid arthritis to determine if there is a difference in the protein expression in the cells that line the blood vessels compared to healthy people.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2011-08 |
| Est. Completion | 2020-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02468986
The ClinicalTrials.gov registry entry for NCT02468986 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02468986 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02468986 about?
NCT02468986 is a clinical study titled "Study of Venous Endothelial Cells in Rheumatoid Arthritis". Heart disease is the major contributor of early death in rheumatoid arthritis (RA) and is not influenced by traditional risk factors. Blood vessel dysfunction has been associated with heart disease and complications such as heart attack. The vessel dysfunction is thought to be mediated in part to in...
What is the current status of trial NCT02468986?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2011-08. Estimated completion is 2020-12.
Who is sponsoring clinical trial NCT02468986?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.